Neurocrine Bioscience buy Piper Sandler
Start price
23.12.24
/
50%
€130.60
Target price
23.12.25
€153.97
Performance (%)
-6.36%
End price
24.12.25
€122.30
Summary
This prediction ended on 24.12.25 with a price of €122.30. With a performance of -6.36%, the BUY prediction for Neurocrine Bioscience by Piper_Sandler closed slightly in the red. Piper_Sandler has a follow-up prediction for Neurocrine Bioscience where he still thinks Neurocrine Bioscience is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | 3.309% | 3.309% | 11.443% |
| iShares Core DAX® | 0,75 % | -8,50 % | 2,57 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % | 15,68 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % | 29,65 % |
| iShares S&P 500 | -0,59 % | -2,87 % | 9,96 % |
Comments by Piper_Sandler for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $160.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
€136.35
06.05.26
06.05.26
8.92%
09:32
09:32
Stopped prediction by Piper_Sandler for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.85
29.10.25
29.10.25
€153.67
29.10.26
29.10.26
-3.31%
09:32
09:32
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€115.25
31.07.25
31.07.25
€153.09
31.07.26
31.07.26
0.09%
09:32
09:32